Lancement du test Novaplex™ MPXV/OPXV plus Assay (RUO) conçu pour détecter le clade I, dont les taux de transmission et de mortalité sont plus élevés que ceux du clade II. Le test est conforme aux profils de […]
Tag: Pharmaceuticals
Senhwa Biosciences Announces IND Submission to US FDA for Pilot Study of Pidnarulex Pharmacodynamics in Patients with Advanced Solid Tumors sponsored by NCI
TAIPEI and SAN DIEGO, Sept. 17, 2024 /PRNewswire/ — Senhwa Biosciences, Inc. (TPEx: 6492), , a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today announced that an Investigational […]
Viatris Announces Early Tender Results and Increase of Pending Maximum Tender Offer
PITTSBURGH, Sept. 17, 2024 /PRNewswire/ — Viatris Inc. (NASDAQ: VTRS, “Viatris” or the “Company”) announced today the early tender results of the previously announced cash tender offer (the “Maximum Tender Offer”) of its subsidiary Utah […]
C3® Pharmaceuticals, Inc. Announces Upcoming Listing on the Canadian Securities Exchange
Manufacturer of Idrasil™, the first standardized medical cannabis, launches after 14 years of research and development, takes aim at U.S. pharmaceutical industry and its opioid epidemic. ANAHEIM, Calif., Sept. 17, 2024 /PRNewswire/ — C3 Pharmaceuticals, Inc., […]
Expanding the Bispecific Antibody Market from CAR-Ts to Drive Follicular Lymphoma’s Future
The competition in follicular lymphoma is rapidly intensifying, with three CAR-T therapies and three bispecific antibodies now approved for relapsed or refractory patients. As both classes of treatments expand, the battle for dominance in this […]
